| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |